Form: 10-K

Annual report pursuant to Section 13 and 15(d)

February 23, 2017

Exhibit 21.1

Subsidiaries of the Registrant

 
EyeGate Pharma S.A.S.   (France)
Jade Therapeutics, Inc.   (United States)